During the past decade, Vascular Care Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vascular Care Group" #1 collaborator was "Veranex, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Vascular Care Group" are "Peripheral Arterial Disease" (2 trials), "Peripheral Artery Occlusion" (1 trials) and "Venous Reflux" (1 trials). Many other conditions were trialed in "Vascular Care Group" in a lesser frequency.

Most popular intervention types in "Vascular Care Group" are "Device" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "AngioSafe Peripheral CTO Crossing System" (1 trials), "BioMimics 3D Vascular Stent System" (1 trials), "Endothermal Ablation (ETA)" (1 trials), "Surgical Stripping" (1 trials) and "VenaSeal™ Closure System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vascular Care Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Vascular Care Group". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Vascular Care Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vascular Care Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".